Skip to main content
BRS5 — Gut–Brain Axis & Enteric Nervous System: vagal pathways, gut barrier, and microbial signalling

BRS5 - Gut-Brain Axis & Enteric Nervous System​

(Gut Barrier, Microbial Signalling & Gut–Brain Neural Pathways)

All Mechanisms of BRS5

Ambition​

Maintain a resilient gut–brain interface — barrier selective, microbial ecology supportive, and gut-to-brain communication proportionate — so the brain receives stable microbial and neural signals without chronic immune activation or inflammatory spillover.

Rationale for inclusion as a distinct BRS​

The gut–brain interface was defined as a distinct BRS because it coordinates barrier selectivity, microbial metabolite signalling and gut–vagal / enteric neural traffic as a peripheral-to-central communication layer. These interconnected processes can change immune exposure, precursor and short-chain fatty-acid availability, and autonomic-linked transmitter tone. BRS5 is therefore represented as a conditional interface system: its signals may reach BRS1, BRS3, BRS4 or BRS6 directly or through mediated routes, but they do not replace host enzymatic regulation. It is not presented as a universal microbiome explanation for brain-related conditions, but as a coherent, diet-responsive gut–brain system with biologically traceable, often context-dependent dependencies across the wider regulatory network.

Therapeutic Area Research​

ADHD is the first fully mapped therapeutic area within the BRAIN Framework, providing a proof of concept for an adaptive biological architecture linking nutrition, biology and function. The same framework is designed to expand across additional therapeutic areas through the shared Phenome Registry.

Dietary and Lifestyle Levers​

Maintaining a resilient gut–brain interface depends on consistent fermentable-substrate intake, dietary plant diversity and steady meal rhythm rather than isolated probiotic or fibre interventions. Meal quality, eating regularity, sleep and stress recovery collectively shape microbial metabolites, immune regulation and vagal signalling that support stable gut–brain communication.

The following dietary guidance summarises the principal dietary patterns, shared nutrient pools and representative food sources that support the biological constraints underlying BRS5. The guidance reflects shared biological principles rather than prescriptive recommendations; individual requirements and optimal dietary patterns will vary according to physiology, health status and the wider diet.

Functional Mechanisms​

Gut barrier integrity, microbial metabolite signalling, and vagal–enteric neuromodulation link the gut interface to brain chemistry, immune tone, and stress responses. These routes determine whether gut-derived signals support or strain neurotransmission, inflammation, and metabolic recovery.

Cross-BRS Dependencies​

Gut biology extends well beyond digestion. Barrier integrity, microbial metabolite signalling and vagal–enteric traffic continuously reshape immune tone, metabolic inputs and neurochemical regulation. Dysfunction at the gut–brain interface rarely produces an isolated gastrointestinal phenotype — it propagates through neurotransmission, inflammation and stress-axis biology.

  • (BRS5 → BRS1) Gut–Vagal Modulation of Neurotransmitter RegulationOpen →
  • (BRS5 → BRS3) Gut–Immune Drivers of Inflammatory ToneOpen →
  • (BRS5 → BRS4) Gut-Metabolic Inputs to Mitochondrial EnergeticsOpen →
  • (BRS5 → BRS6) Gut–Vagal Influence on Stress-Axis RegulationOpen →

Specific Mechanisms​

Specific Mechanisms (SMs) are interpretation layers — context-specific readings of stable BRS5 biology grounded in connected PMs, FMs, and KCs. They provide additional biological context for applying the BRAIN Framework. Current SM categories include SM-SNP (genetic variation), SM-CROSS (multi-BRS interpretive concepts), SM-Male and SM-Female (sex-specific biology), SM-Lifestage (e.g. childhood, pregnancy, older adulthood), and SM-Pattern (e.g. vegan, vegetarian, ketogenic). Functional phenotype interpretation is handled via the Phenome Registry rather than SM-PHEN pages. Individual SMs may be combined to create richer biological profiles and support future precision-nutrition applications.

References​

[1] Prehn-Kristensen et al. (2018). Reduced microbiome alpha diversity in young patients with ADHD. Reduced microbial alpha diversity reported in paediatric ADHD cohorts.

[2] Aarts et al. (2017). Gut microbiome in ADHD and its relation to neural reward anticipation. Gut microbiome composition linked to neural reward anticipation in ADHD.

[3] Jiang et al. (2018). Gut microbiota profiles in treatment-naïve children with attention deficit hyperactivity disorder. Compositional differences in gut microbiota profiles in treatment-naïve children with ADHD, including beneficial taxa guild shifts.

[4] Steckler et al. (2024). Disrupted gut harmony in attention-deficit/hyperactivity disorder: Dysbiosis and decreased short-chain fatty acids. ADHD cohorts showed lower faecal SCFA levels including acetic, propionic, isobutyric, isovaleric, and valeric acids versus controls.

[5] Wang et al. (2022). Effect of Bifidobacterium bifidum on Clinical Characteristics and Gut Microbiota in Attention-Deficit/Hyperactivity Disorder. Open-label Bifidobacterium bifidum supplementation associated with symptom change and altered gut microbiota in children with ADHD.

[6] Pärtty et al. (2015). A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Early-life Lactobacillus rhamnosus GG exposure with later neurodevelopmental risk associations including ADHD; hypothesis-generating developmental modulation window rather than definitive prevention.

[7] Schleupner & Carmichael (2022). Attention-Deficit/Hyperactivity Disorder and the Gut Microbiota–Gut–Brain Axis: Closing Research Gaps through Female Inclusion in Study Design. ADHD-focused review of gut microbiota–gut–brain axis research gaps, including female inclusion in study design.

[8] Bravo et al. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Demonstrated that gut microbiota modulate HPA-axis stress responses via vagal pathways — supporting the framework interpretation that BRS5 gut–vagal signalling shapes BRS6 stress-axis responsiveness.

[9] Jaggar et al. (2020). You've got male: Sex and the microbiota-gut-brain axis across the lifespan. Synthesised microbial metabolite signalling intersecting metabolic and neuroendocrine adaptive regulation — supporting the interpretation of BRS5 as an upstream enabler of BRS4 bioenergetic performance.

[10] O’Mahony et al. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Synthesised microbiota–gut–brain communication pathways linking gut ecology to peripheral and central inflammatory biology — supporting the framework interpretation that BRS5 gut–immune signalling shapes BRS3 inflammatory tone.

[11] Slavich & Irwin (2014). From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Established stress-to-inflammation signalling as a systems-level pathway reshaping immune and neuroendocrine biology — supporting the interpretation that gut–immune perturbation can propagate inflammatory burden across BRS3 and connected systems.

[12] Picard et al. (2014). Mitochondrial allostatic load puts the 'gluc' back in glucocorticoids. Linked mitochondrial energy metabolism, glucose handling and stress-related pathophysiology — supporting the framework interpretation that metabolic and neuroendocrine load shapes bioenergetic capacity within BRS4.

[13] Thayer et al. (2012). A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health.. Linked autonomic regulatory capacity to stress neurobiology and central nervous system function — supporting the interpretation of vagal–neuroendocrine integration as a BRS5 → BRS6 enabling pathway.